中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Recent progress in assays for GPCR drug discovery

文献类型:期刊论文

作者Guo, Shimeng1; Zhao, Tingting2; Yun, Ying3; Xie, Xin1,2,3,4
刊名AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
出版日期2022-08-01
卷号323期号:2页码:C583-C594
关键词biased signaling GPCR high -throughput screening assays humanized mouse model protein protein interaction
ISSN号0363-6143
DOI10.1152/ajpcell.00464.2021
通讯作者Xie, Xin(xxie@simm.ac.cn)
英文摘要G-protein-coupled receptors (GPCRs), also known as seven transmembrane receptors, are the largest family of cell surface receptors in eukaryotes. There are -800 GPCRs in human, regulating diverse physiological processes. The GPCRs are the most intensively studied drug targets. Drugs that target GPCRs account for about a quarter of the global market share of therapeutic drugs. Therefore, to develop physiologically relevant and robust assays to search new GPCR ligands or modulators remain the major focus of drug discovery research worldwide. Early functional GPCR assays mainly depend on the measurement of G-protein-mediated second messenger generation. Recent developments in GPCR biology indicate that the signaling of these receptors is much more complex than the oversimplified classical view. The GPCRs have been found to activate multiple G proteins simultaneously and induce b-arrestin-mediated signaling. They have also been found to interact with other cytosolic scaffolding proteins and form dimer or heteromer with GPCRs or other transmembrane proteins. Here, we mainly discuss technologies focused on detecting protein-protein interactions, such as fluorescence resonance energy transfer/bioluminescence resonance energy transfer (FRET/BRET), NanoLuc binary technology (NanoBiT), Tango, etc., and their applications in measuring GPCRs interacting with various signaling partners. In the final part, we also discuss the species differences in GPCRs when using animal models to study the in vivo functions of GPCR ligands, and possible ways to solve this problem with modern genetic tools.
WOS关键词PROTEIN-COUPLED-RECEPTOR ; RESONANCE ENERGY-TRANSFER ; MU-OPIOID RECEPTOR ; SEVERE ACUTE PAIN ; LIVE CELLS ; ACTIVATION ; COMPLEMENTATION ; OLICERIDINE ; REVEALS ; BINDING
资助项目National Natural Science Foundation of China[82121005] ; National Natural Science Foundation of China[81730099] ; National Natural Science Foundation of China[82030109] ; Ministry of Science and Technology China Brain Initiative[2022ZD0204701] ; Shanghai Municipal Science and Technology Major Projects[TM202101H005] ; Shanghai Municipal Science and Technology Major Projects[20S11903200]
WOS研究方向Cell Biology ; Physiology
语种英语
WOS记录号WOS:000889459900005
出版者AMER PHYSIOLOGICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/304533]  
专题新药研究国家重点实验室
通讯作者Xie, Xin
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai, Peoples R China
2.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing, Peoples R China
3.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou, Peoples R China
4.Shanghai Inst Mat Med, Chinese Acad Sci, State Key Lab Drug Res, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Guo, Shimeng,Zhao, Tingting,Yun, Ying,et al. Recent progress in assays for GPCR drug discovery[J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY,2022,323(2):C583-C594.
APA Guo, Shimeng,Zhao, Tingting,Yun, Ying,&Xie, Xin.(2022).Recent progress in assays for GPCR drug discovery.AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY,323(2),C583-C594.
MLA Guo, Shimeng,et al."Recent progress in assays for GPCR drug discovery".AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY 323.2(2022):C583-C594.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。